Stock CNTG CENTOGENE N.V.
Add to a list
To use this feature you must be a member
Log inSign up

All News Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq
Other stock markets
 02:00:00 29/06/2024 am IST 		5-day change 1st Jan Change
0.38 USD -2.64% Intraday chart for Centogene N.V. -1.81% -68.33%
20/06 Critical Path Institute and Centogene N.V. Announces the Signing of A Memorandum of Understanding to Advance Drug Development for Lysosomal Diseases CI
16/05 Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
GL
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
AQ
Critical Path Institute and Centogene N.V. Announces the Signing of A Memorandum of Understanding to Advance Drug Development for Lysosomal Diseases
CI
Centogene N : Minutes of the 2024 Annual General Meeting of Shareholders - Centogene N.V.
PU
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
GL
Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday
MT
Top Premarket Gainers
MT
Centogene N : KSA RECEIVABLES TRANSFER AGREEMENT - Form 6-K
PU
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
GL
Centogene N.V. Provides Earnings Guidance for the Year 2024
CI
Centogene N.V. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
GL
Centogene N : Voting Proxy AGM 2024
PU
Centogene N : Convening Notice and Agenda (incl. explanatory notes) (AGM 2024)
PU
Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment
MT
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GL
Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease
CI
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
AQ
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
GL
Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNTG Stock
  4. News Centogene N.V.